Latest News

April 24, 2017

Former FDA Associate Commissioner Jill Hartzler Warner Joins Catalyst Team, Expanding the Firm’s Expertise in Regenerative Medicine, Rare Disease Drug Development and Combination Product Regulation

April 24, 2017 / 0 Comments 0 Comments
Press release Washington, DC – Catalyst Healthcare Consulting is pleased to announce that Jill Hartzler Warner, JD, has joined the firm as Vice President, Regulatory Policy. She will advise clients… read more →
April 20, 2017

Trump’s Deregulatory Agenda: What It Could Mean For Biopharma & Medtech Companies

April 20, 2017 / 0 Comments 0 Comments
Pharmaceutical Online-  What do President Trump’s deregulatory executive orders mean for the industry? In this article in Pharmaceutical Online, Catalyst’s Nancy Bradish Myers and Anne Petruska McNickle explore Trump’s “2-for-1”… read more →
January 24, 2017

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

January 24, 2017 / 0 Comments 0 Comments
The Pink Sheet—  In this analysis piece, The Pink Sheet looks at the potential impact of the Trump Administration’s federal hiring freeze on the FDA – specifically, FDA positions supported… read more →

View News Archive

Latest Events

March 1, 2017

DIA Annual Meeting 2017: CRISPR, Disruptive Innovation Panels to be Moderated by Catalyst

March 1, 2017 / 0 Comments 0 Comments
Catalyst will moderate two panel discussions exploring various types of disruptive innovation during the DIA’s 2017 Annual Meeting. On June 20, Catalyst President Nancy Bradish Myers will moderate a panel… read more →
February 15, 2017

RxAdherence Annual Meeting: Catalyst to Present on FDA and the Trump Administration

February 15, 2017 / 0 Comments 0 Comments
During the RxAdherence “Strategies to Improve Outcomes” annual meeting, Catalyst President Nancy Bradish Myers will give a presentation on FDA the Trump Administration. Ms. Myers’ presentation at the 2017 annual… read more →
February 1, 2017

FDA and the Trump Administration: Catalyst To Participate in FDLI Annual Conference Panel

February 1, 2017 / 0 Comments 0 Comments
This year’s Food & Drug Law Institute Annual Conference will feature a panel on FDA under the Trump Administration. Catalyst President Nancy Bradish Myers will join the panel, which will… read more →

View Events Archive

Back to Top